Βιβλιογραφική Τεκμηρίωση:
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.J Allergy Clin Immunol. 2001 Aug;108(2):184-90.
Anti-IgE monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review.Hong CJ, Tsang AC, Quinn JG, Bonaparte JP, Stevens A, Kilty SJ.Syst Rev. 2015 Nov 18;4:166.
Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.Berger WE.Ann Allergy Asthma Immunol. 2002 Feb;88(2):152-60; quiz 161-2, 208.